Clinical Trials Browser

NCT07424664 2026-02-20

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

Phase 2 Not yet recruiting

30 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence, Vaginal Neoplasms, Vulvar Neoplasms

NCT07290894 2025-12-18

MITO VULVA-01

Phase 2 Not yet recruiting

80 enrolled

Gynecologic

Vulvar Neoplasms

NCT07267780 2025-12-05

Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.

Not yet recruiting

130 enrolled

Gynecologic

Uterine Cervical Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06476639 2025-11-28

ANVU

Phase 3 Not yet recruiting

640 enrolled

Gynecologic

Lymphatic Metastasis, Vulvar Neoplasms

NCT06035068 2025-09-29

SLN Mapping and ICG Dye for Vulvar Cancer

Not yet recruiting

10 enrolled

Gynecologic

Vulvar Neoplasms

NCT07101848 2025-08-03

BRAVA VULVAR

Phase 2 Not yet recruiting

42 enrolled

Gynecologic

Vulvar Neoplasms

NCT06871787 2025-03-14

INOCA

Phase 4 Not yet recruiting

50 enrolled

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Anastomotic Leak

NCT06582108 2024-09-03

ROAR

Not yet recruiting

190 enrolled

Gynecologic

Vulvar Neoplasms

NCT06505551 2024-07-17

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

Phase 1/2 Not yet recruiting

66 enrolled

GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT06392399 2024-05-02

Interventions for the Management of Perineal Cancer Pain

Phase NA Not yet recruiting

60 enrolled

GastrointestinalGynecologic

Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT06202339 2024-01-31

Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).

Phase NA Not yet recruiting

10 enrolled

Gynecologic

Neoplasms, Vulvar Neoplasms

NCT06039111 2023-09-15

IGNITE-V

Phase 2 Not yet recruiting

58 enrolled

Gynecologic

Vulvar Neoplasms